Merger news has revived this penny stock 🙌

Trades on our radar TODAY 🚀                                                                                                                                                                                                                                                                                                                                                                                                                 February 23, 2023 | [Read Online]( *Together with Good day, 360 – Here are our top 3 trade ideas today – these setups look primed! Be the best prepared trader on the Street...and please throw some love to our Sponsor [alts.co]( today — thank you 🫶 VBLT - 80% higher on merger news LUNR - 2nd day play, low float Intuitive Machines closes up 116% NVDA - 10% higher after beating on the top and bottom line *A message from Alternative Assets WTF is an NFT? Alternative Assets demystifies and explains the hottest unique investment ideas out there. Collectibles, NFTs, Wine, Websites, even LEGOs. They don't just track the markets, they SMASH the markets. [Subscribe to Alternative Assets (ALTS) today.]( *Sponsored content, see disclosures below. VBLT - 80% higher on merger news Vascular Biogenics (VBLT) announced this morning that it had entered into a definitive merger agreement with Notable Labs that is expected to close in Q2 of 2023. The merger would also include a $10.3 million investment from Notable prior to closure of the deal leaving the combined company with cash runway into 2025. Prior to this announcement, VBLT had a market cap of just $9.38 million according to Finviz based on yesterday’s close. The pre-market high was $0.2580 and would be the first major target for bulls. Above it, the first major resistance level is $0.2730, with $0.30, $0.4 and $0.4777 above that. Above that there is a lot of gap to fill and $1 would be a psychological level. Below $0.2580 there is potential support at $0.2050, $0.1817 with $0.1490 below that. LUNR - 2nd day play, low float Intuitive Machines (LUNR) closes up 116% After running over 250% on Thursday, LUNR consolidated for 2 days before closing up over 116% yesterday. The stock is gapping another 30% higher this morning in the pre-market. LUNR has a float of just over 4 million shares according to Finviz and is having wild moves on light volume. The $90-$93 level was an area of support yesterday and should be an important pivot level today. Above it, targets to the upside are $120, and then yesterday’s high of $136. Above $136 there is blue sky, and no telling how high this can go. We’ve seen stocks like this in the past go $1000+ so risk management is key here. Below $90, there is a gap to fill to $81.99, and the next potential support levels are $73 with $50 and then $40 below that. NVDA - 10% higher after beating on the top and bottom line Nvidia (NVDA) reported Q4 EPS of $0.88 vs the $0.81 analyst estimate. Revenue came in at $6.05 billion vs the $6.01 billion consensus estimate for Q4. NVDA also guided Q1 2023 revenue of $6.5 billion vs the $6.33 billion consensus. It should be noted that NVDA is also an A.I. play as A.I. and machine learning relies heavily on graphics chips. The $226 was resistance in the after hours and becomes potential support today. Above it the first major target is $230/$230.50 where NVDA failed on 2 previous occasions. Above that, there is a gap to fill at $242.08 and $250 becomes a short term psychological target. Below $226 the next target to the downside is $220, followed by $210 and a gap to fill at $207.54. Economic Calendar (EST) 8:30am Initial jobless claims 8:30am Chicago fed activity. 10:30am Natural gas report 10:50am Fed speaker Bostic 11:00am EIA petroleum report 11:00am Fed mfg index 2:00pm Fed speaker Daly Earnings for Today (After Market) AAOI, ACA, ACCO, ADSK, ALKT, ALRM, ALTR, AMEH, AMH, ATSG, BALY, BBDC, BCOV, BECN, BIGC, BKNG, BLI, BOOM, BTE, BWMX, BWXT, BYND, CABO, CDXS, CE, CENX, CHE, CIB, COLL, CRC, CTO, CUBE, CVNA, CWK, CYRX, DAIO, DH, DVAX, EFC, EGO, EIX, ENV, EOG, ERF, ERIE, EXFY, FND, FOXF, FTAI, FTCH, GDOT, GDYN, GH, GLPI, GPMT, GSBD, INFN, INGN, INT, INTU, IRTC, KAMN, KOF, KTOS, KURA, KWR, LASR, LAW, LMAT, LNT, LPRO, LSI, LYV, LZ, MAIN, MAX, MCW, MDRX, MELI, MNKD, MORN, MP, MRIN, MTZ, NOG, NTST, NVEE, NVTS, OII, OLED, OPEN, OPK, ORC, ORGN, PAY, PBA, PEN, PLYA, PODD, PRDO, PRI, PRTA, PSNL, PSTV, RCEL, RCKY, RHP, RVLV, SEM, SG, SPNT, SPXC, SQ, STTK, SWN, TMST, TUSK, UPLD, UVE, VAPO, VICI, VICR, WBD, WISH, XNCR, ZETA, ZEUS Top Headlines FOLD: Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium™ 2023 ISR: Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session ABBV: AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need AZN: AstraZeneca to pay KYM $63M upfront in license deal for potential gastric cancer therapy WLDS: Wearable Devices to Showcase its AI-Based Air-Touch Technology for Apple Ecosystem at MWC Barcelona 2023 MAXR: Maxar Launches High-Performance SYNTH3D Digital Twin for Metaverse, Simulation and Virtual Reality Applications MSFT: Microsoft wants to cut up to 120 jobs in Germany -WIW0 BIOL: Biolase enters the skin resurfacing market in the U.S. with the launch of a new waterlase fractional handpiece DEN: Aqualung Carbon Capture Announces Denbury as Strategic Investor PERF: Perfect Corp. Unveils 2023 Upgrade to AI Skin Analysis Solution, Adding Real-Time Skin Concern Detection, Skincare Product Suggestions and Routine Recommendations, Further Enhancing the Industry-Leading Solution SO: Southern Company announces offering of $1.5 billion in aggregate principal amount of Convertible Senior Notes due December 15, 2025 SWI: SolarWinds Expands Global Reach of World-Class SaaS Observability Solution to Help Customers Accelerate Digital Transformation and Reduce IT Complexity VBLT: VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement INAB: IN8bio Presents Preclinical Data Showing Non-Signaling CAR Platform Targets Cancer Cells While Preserving Healthy Tissue GNPX: Genprex Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Gene Therapy to Treat Type 1 Diabetes at 16th Annual International Conference on Advanced Technologies & Treatment for Diabetes 2023 MEIP: MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates ALDX: Aldeyra Therapeutics Announces Next-Generation RASP-Modulator Drug Candidates Expected to Begin Clinical Trials for Systemic Immune-Mediated Diseases and Geographic Atrophy OMGA: Omega Therapeutics Announces $40 Million Registered Direct Offering of Common Stock AVIR: Atea Pharmaceuticals Presents Favorable Drug Interaction Profile of Bemnifosbuvir in Phase 1 Studies at CROI 2023 HRZN: Monroe Capital Announces Agreement to Acquire Horizon Technology Finance Management, Market Leader in Venture Lending NEM: Newmont Announces Increased 2022 Mineral Reserves of 96 Million Gold Ounces and 68 Million Gold Equivalent Ounces MRNA: Moderna forecasts 2023 covid vaccine sales below market expectations PSN: Parsons Awarded $30 Million to Improve Water Quality, Seismic Stability, and Safety for Valley Water DPRO: Vermeer Partners with Draganfly to Offer Enhanced Mission Capabilities in GPS-Denied and Spoofed Environments for the Defense Industry To Your Success! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions DISCLAIMER: To more fully understand RagingBull.com, LLC’s issuer-paid advertisement disclaimer and disclosure policy located at [(. *ISSUER-PAID ADVERTISEMENT. RagingBull expects to receive around $1000 in compensation. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Raging Bull nor any of its owners, employees OR INDEPENDENT CONTRACTORS is CURRENTLY registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements.In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](